Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atrial Fibrillation (Prevention of Stroke)”

122 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 122 results

Post-approval studies (Phase 4)Study completedNCT01493557
What this trial is testing

A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,067
Not applicableStudy completedNCT02478294
What this trial is testing

LAA Excision With AF Ablation Versus Oral Anticoagulants for Secondary Prevention of Stroke

Who this might be right for
Atrial FibrillationStrokeSystemic Embolism
The First Affiliated Hospital with Nanjing Medical University 474
Large-scale testing (Phase 3)Ended earlyNCT05643573
What this trial is testing

Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke

Who this might be right for
Prevention of Stroke or Systemic EmbolismAtrial Fibrillation
Bayer 14,830
Not applicableUnknownNCT02147444
What this trial is testing

Evaluation of Effectiveness and Safety of Xa Inhibitor for the Prevention of Stroke And Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-valvular Atrial Fibrillation

Who this might be right for
Non-valvular Atrial Fibrillation
Tohoku University 7,000
Post-approval studies (Phase 4)Looking for participantsNCT04642430
What this trial is testing

COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Ottawa Hospital Research Institute 3,018
Not applicableActive Not RecruitingNCT02830152
What this trial is testing

Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Patients After Intracerebral Hemorrhage

Who this might be right for
Atrial FibrillationStrokeIntracerebral Hemorrhage
Karolinska Institutet 750
Not applicableStudy completedNCT04322474
What this trial is testing

Russian National Registry of LAAO

Who this might be right for
Atrial Fibrillation
National Research Center for Preventive Medicine 200
Not applicableStudy completedNCT01925755
What this trial is testing

Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation Patients

Who this might be right for
StrokeEmbolism
Bayer 209
Not applicableEnded earlyNCT02793895
What this trial is testing

Detection of Atrial Fibrillation After Cardiac Surgery

Who this might be right for
Atrial FibrillationAtrial FlutterC.Surgical Procedure; Cardiac+1 more
Unity Health Toronto 336
Not applicableStudy completedNCT02585076
What this trial is testing

A Cross-sectional Study for the Determination of the Prevalence of Non-valvular Atrial Fibrillation Among Patients Diagnosed With Hypertension

Who this might be right for
HypertensionAtrial Fibrillation
Bayer 1,119
Large-scale testing (Phase 3)Study completedNCT01674647
What this trial is testing

Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion

Who this might be right for
Atrial Fibrillation
Bayer 1,504
Post-approval studies (Phase 4)Study completedNCT03126214
What this trial is testing

Improving Stroke Prevention in Atrial Fibrillation Through Pharmacist Prescribing

Who this might be right for
Atrial FibrillationStroke
University of Alberta 79
Not applicableActive Not RecruitingNCT06580275
What this trial is testing

The GLACE Study: Evaluating CLAAS With ICE Guided LAA Closure

Who this might be right for
Atrial FibrillationStroke Prevention
Conformal Medical, Inc 80
Not applicableStudy completedNCT03826927
What this trial is testing

New Oral Anticoagulants (NOAC) in Stroke Patients

Who this might be right for
StrokeAtrial Fibrillation
University Hospital, Basel, Switzerland 1,023
Not applicableLooking for participantsNCT07036965
What this trial is testing

Comparison of Different Pulsed Field Ablation Catheters in Atrial Fibrillation

Who this might be right for
Atrial Fibrillation (AF)
Hangzhou Dinova EP Technology Co., Ltd 292
Post-approval studies (Phase 4)WithdrawnNCT01668901
What this trial is testing

Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney Disease

Who this might be right for
Atrial FibrillationChronic Kidney Disease
Seoul National University Hospital
Not applicableStudy completedNCT03887780
What this trial is testing

Evaluate the Safety and Effectiveness of Rivaroxaban (Xarelto) for Prevention of Stroke and Systemic Embolism in Indian Patients With Non-valvular Atrial Fibrillation (NVAF)

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bayer 504
Testing effectiveness (Phase 2)Study completedNCT00623779
What this trial is testing

Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA)

Who this might be right for
Persistent or Permanent Non-valvular Atrial Fibrillation
AstraZeneca 128
Not applicableStudy completedNCT03867227
What this trial is testing

Non-pharmacological Prevention of Stroke in Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
National Research Center for Preventive Medicine 300
Not applicableNot Yet RecruitingNCT06564012
What this trial is testing

Wearable Cardiac Monitor to Enhance Detection of Arrhythmia Recurrence After Catheter Ablation of Atrial Fibrillation

Who this might be right for
Atrial FibrillationArrhythmias, CardiacHeart Diseases+2 more
Sunnybrook Health Sciences Centre 100
Next Page